ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,749, issued on Oct. 28, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Recombinant rhabdovirus encoding for CCL21" was invented by Philipp Mueller (Mittelbiberach, Germany), Klaus Erb (Mittelbiberach, Germany), Patrik Erlmann (Goetzens, Austria), Tobias Friederike Nolden (Birgitz, Austria), John Edward Park (Warthausen, Germany) and Guido Wollmann (Innsbruck, Austria).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of oncolytic viruses and in particular to a recombinant rhabdovirus, such as vesicular stomatitis virus encoding in its genome for a CCL21 protein. The inve...